Publikasi Scopus 2024 per tanggal 31 Juli 2024 (607 artikel)

Strahan A.G., Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States, Mercer University School of Medicine, Savannah, GA, United States; Davies O.M.T., Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States, Harvard Medical School Combined Dermatology Program, Boston, MA, United States; Fernández L.T., Department of Dermatology, Hospital Universitario José E. Gonzalez, Monterrey, Mexico; Gaylord I.W.I., Department of Dermatology, Hopital du Cinquantenaire de Kisangani, Kisangani, Democratic Republic Congo; Mekonnen Y.G., Department of Dermatology, College of Health and Medical Science, Haramaya University, Harar, Ethiopia; Grijsen M.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Ollague J.E., Hospital General Guasmo Sur, Guayaquil, Ecuador; Sabushimike D., Hopital Militaire de Kamenge, Bujumbura, Burundi; Silveira L.P., Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States; Maurer T., Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, United States; Dodiuk-Gad R.P., Department of Dermatology, Emek Medical Center, Afula, Israel, Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada, Department of Dermatology, Bruce Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel; Singal A., Department of Dermatology, University College of Medical Sciences & G.T.B. Hospital, Dilshad Garden, Delhi, India; Lim H.W., Department of Dermatology Henry Ford Health, Detroit, MI, United States, International League of Dermatological Societies, London, United Kingdom; Bhose A., International League of Dermatological Societies, London, United Kingdom; Lubov J.E., Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States, Wright State University Boonshoft School of Medicine, Dayton, OH, United States; Jain S., Louisiana State University Health Sciences Center New Orleans, New Orleans, LA, United States; Zehtab M., Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States; Allison T., CeraVe L Oréal Group, New York, NY, United States; Guerin M., CeraVe L Oréal Group, New York, NY, United States; Enbiale W., Department of Dermatology, College of Health Sciences and Medicine, Bahir Dar University, Bahir Dar, Ethiopia, Department of Dermatology, Amsterdam Institute for Infection and Immunity (AII), Academic Medical Centre, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Rehmus W., Division of Dermatology, BC Children s Hospital, University of British Columbia, Vancouver, BC, Canada; Wanat K.A., Department of Dermatology and Pathology, Medical College of Wisconsin, Milwaukee, WI, United States; Claire Fuller L., London Bridge Hospital, London, United Kingdom, International Foundation for Dermatology, London, United Kingdom; Bailey E., Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, United States; Freeman E.E., Department of Dermatology, Massachusetts General Hospital, Boston, MA, United States, International Foundation for Dermatology, London, United Kingdom, Medical Practice Evaluation Foundation, Massachusetts General Hospital, Boston, MA, United States